Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 24531 | 259 | 32.3 | 68% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 3102 | 1835 | MEYERS INTERDISCIPLINARY ORGAN MED CHE//BLEOMYCIN HYDROLASE//BLEOMYCIN AMPLIFICATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BLEOMYCIN AMPLIFICATION | Author keyword | 12 | 86% | 2% | 6 |
| 2 | PHENYLACETATE | Author keyword | 9 | 34% | 8% | 21 |
| 3 | ANTINEOPLASTON AS2 1 | Author keyword | 6 | 100% | 2% | 4 |
| 4 | PHENYLBUTYRATE | Author keyword | 4 | 23% | 7% | 17 |
| 5 | ANTINEOPLASTON A10 | Author keyword | 4 | 75% | 1% | 3 |
| 6 | SODIUM PHENYLACETATE NAPA | Author keyword | 3 | 100% | 1% | 3 |
| 7 | ANTINEOPLASTONS | Author keyword | 2 | 67% | 1% | 2 |
| 8 | AROMATIC FATTY ACIDS | Author keyword | 2 | 67% | 1% | 2 |
| 9 | SODIUM PHENYLACETATE | Author keyword | 2 | 36% | 2% | 4 |
| 10 | HEMOSTASE ENDOTHELIUM ANGIOGENESE | Address | 1 | 38% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BLEOMYCIN AMPLIFICATION | 12 | 86% | 2% | 6 | Search BLEOMYCIN+AMPLIFICATION | Search BLEOMYCIN+AMPLIFICATION |
| 2 | PHENYLACETATE | 9 | 34% | 8% | 21 | Search PHENYLACETATE | Search PHENYLACETATE |
| 3 | ANTINEOPLASTON AS2 1 | 6 | 100% | 2% | 4 | Search ANTINEOPLASTON+AS2+1 | Search ANTINEOPLASTON+AS2+1 |
| 4 | PHENYLBUTYRATE | 4 | 23% | 7% | 17 | Search PHENYLBUTYRATE | Search PHENYLBUTYRATE |
| 5 | ANTINEOPLASTON A10 | 4 | 75% | 1% | 3 | Search ANTINEOPLASTON+A10 | Search ANTINEOPLASTON+A10 |
| 6 | SODIUM PHENYLACETATE NAPA | 3 | 100% | 1% | 3 | Search SODIUM+PHENYLACETATE+NAPA | Search SODIUM+PHENYLACETATE+NAPA |
| 7 | ANTINEOPLASTONS | 2 | 67% | 1% | 2 | Search ANTINEOPLASTONS | Search ANTINEOPLASTONS |
| 8 | AROMATIC FATTY ACIDS | 2 | 67% | 1% | 2 | Search AROMATIC+FATTY+ACIDS | Search AROMATIC+FATTY+ACIDS |
| 9 | SODIUM PHENYLACETATE | 2 | 36% | 2% | 4 | Search SODIUM+PHENYLACETATE | Search SODIUM+PHENYLACETATE |
| 10 | ANTINEOPLASTON | 1 | 100% | 1% | 2 | Search ANTINEOPLASTON | Search ANTINEOPLASTON |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | STEREOCHEMICAL COMPLEMENTARITY | 23 | 100% | 4% | 10 |
| 2 | SODIUM PHENYLACETATE | 17 | 70% | 5% | 14 |
| 3 | PHENYLACETATE | 10 | 25% | 14% | 35 |
| 4 | BCL 2 DOWN REGULATION | 7 | 56% | 3% | 9 |
| 5 | PHENOTYPIC REVERSION | 6 | 50% | 3% | 9 |
| 6 | CARBOXYMETHYL BENZYLAMIDE DEXTRAN | 5 | 55% | 2% | 6 |
| 7 | ANTINEOPLASTONS | 3 | 100% | 1% | 3 |
| 8 | ANTINEOPLASTON A10 | 3 | 50% | 2% | 4 |
| 9 | AROMATIC FATTY ACIDS | 3 | 60% | 1% | 3 |
| 10 | URINARY PREPARATION | 2 | 67% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Possible Structural and Functional Determinants Contributing to the Clastogenicity of Pharmaceuticals | 2010 | 5 | 40 | 23% |
| ANTINEOPLASTONS - HISTORY OF THE RESEARCH .1. | 1986 | 18 | 5 | 80% |
| EMERGING DIVERSITIES IN THE MECHANISM OF ACTION OF STEROID-HORMONES | 1995 | 203 | 118 | 8% |
| POTENTIAL OF ANTINEOPLASTONS IN DISEASES OF OLD-AGE | 1995 | 4 | 95 | 38% |
| Use of the best case series to evaluate complementary and alternative therapies for cancer: A systematic review | 2002 | 11 | 20 | 15% |
| A Molecular Guidance System Based Upon Target Genes, Nuclear Receptors and Ligands Applied to Drug Discovery and Prediction of Toxicity | 2008 | 0 | 78 | 18% |
| Targeting excessive angiogenesis with functional foods and nutraceuticals | 2003 | 15 | 85 | 4% |
| Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention | 2005 | 4 | 80 | 5% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HEMOSTASE ENDOTHELIUM ANGIOGENESE | 1 | 38% | 1.2% | 3 |
| 2 | EQUIPE ONCOL CELLULAIRE MOL | 1 | 100% | 0.8% | 2 |
| 3 | UNITE 553 | 1 | 50% | 0.8% | 2 |
| 4 | ARBEITSGRP ZYTOMETRIE | 1 | 50% | 0.4% | 1 |
| 5 | ARMED FORCES RADIOBIOL AFRRI | 1 | 50% | 0.4% | 1 |
| 6 | CANC GENOME PROGRAM | 1 | 50% | 0.4% | 1 |
| 7 | CIBLAGE IMAGERIE FONCT PROG S TUMORALE | 1 | 50% | 0.4% | 1 |
| 8 | EQUIPE PHARMACOL | 1 | 50% | 0.4% | 1 |
| 9 | EVERLIFE BIOTECHNOL LTD INCUBATOR | 1 | 50% | 0.4% | 1 |
| 10 | MED RADIAT CANC BIOL | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000190237 | RGTA//DERIVATIZED DEXTRANS//HEPARAN MIMETIC |
| 2 | 0.0000102344 | TRIMETHYLSILYL CATION//MASS SPECTROMETRY CHEMICAL IONIZATION//PARTIAL METHYLATION |
| 3 | 0.0000071843 | HISTONE DEACETYLASE INHIBITOR//HISTONE DEACETYLASE INHIBITORS//HISTONE DEACETYLASE |
| 4 | 0.0000067571 | ORNITHINE TRANSCARBAMYLASE DEFICIENCY//SLC25A13//CITRIN DEFICIENCY |
| 5 | 0.0000058903 | BENFLURON//9 HYDROXYBENFLURON//BENZOCFLUORENE DERIVATIVES |
| 6 | 0.0000057888 | MEVALONIC ACID//MEVALONATE 5 PYROPHOSPHATE DECARBOXYLASE//COMM HUMAN NUTR NUTRIT BIOL |
| 7 | 0.0000055537 | HEXAMETHYLENE BISACETAMIDE//MED SCI SLOAN KETTERING//HMBA |
| 8 | 0.0000052340 | RING TRANSFORMATION REACTION//2H PYRAN 2 ONE//2H PYRAN 2 ONES |
| 9 | 0.0000051780 | MIGRASTATIN//CYCLOHEXYLAMINOGLUTETHIMIDE//JOHNS SCI |
| 10 | 0.0000051613 | METHAPYRILENE//ACRIVASTINE//METHAPYRILENE HYDROCHLORIDE |